Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

THE TRUTH ABOUT: 22 - Caught on Camera

COVID-19 Booster Shot: Study Says Half Dose Of Pfizer Vaccine Produces Strong Immune Response

The team discovered that people who previously received AstraZeneca or Sinopharm COVID-19 vaccines had a "non-inferior" immune response when given a half dose of a Pfizer COVID-19 booster vaccine, comparable to those who received a full dose.

Medical Daily

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

What are the new COVID booster vaccines? Can I get one? Do they work? Are they safe?

As the COVID virus continues to evolve, so does our vaccine response. From December 11, Australians will have access to new vaccines that offer better protection.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

Travis Kelce took a playful swipe at Aaron Rodgers in his interview with The Wall Street Journal

Rodgers isn't coming back from that one.

USA Today Sports Media Group

Exploring side effects

Most meds have side effects, some subtle, some difficult to handle. However, some drugs have positive side effects, like finasteride for hair growth and sildenafil for impotence. Side effects can be monitored and, with shrewdness, can be used to benefit mankind. Be on the lookout for positive effects when taking…

The Hindu

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Barchart

Can Pfizer (PFE) and AbbVie (ABBV) Cure Your Portfolio's Ailments?

The pharmaceutical industry is expected to thrive amid robust demand and technological advancements. Amid this, let’s analyze the fundamentals of AbbVie (ABBV) and Pfizer (PFE) to determine whether these stocks are worth buying now.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Syphilis cases in US newborns skyrocketed in 2022. Health officials suggest more testing

Syphilis cases in U.S. newborns again are on the rise

The Independent UK

COVID-19 treatments to enter the market with a hefty price tag

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag

The Independent UK

On 2023’s 100 Fastest-Growing Companies list, Tesla makes its debut and energy companies take off

Tesla was one of several industrial companies in the top five, while Pfizer and energy giants Chevron and ExxonMobil also put up big numbers.

Fortune

Pfizer and KIMS Hospital launch Center of Excellence for adult vaccination

Pfizer & KIMS Hospital in Hyderabad inaugurated a CoE for Adult Vaccination to equip HCPs & educate patients on enduring advantages of vaccinations. It will reinforce immunisation against Pneumococcal, Hepatitis A/B, HPV & Influenza. CoE symbolises commitment to protecting individuals against respiratory threats & enhancing quality of life.

The Hindu

Company bosses and workers grapple with the fallout of speaking up about the Israel-Hamas war

The fallout from the Israel-Hamas war has spilled into workplaces everywhere, with corporate leaders from the highest ranks of prominent companies weighing in with their views while workers complain their voices are not being heard

The Independent UK

Pfizer doubling cost of Paxlovid

One of the most effective treatments for COVID is going to get a lot more expensive, but Pfizer insists it's fine

Salon

Why is Covid-19 Still Affecting the Healthcare Industry?

Back in May, the World Health Organization declared an end to the global Public Health Emergency for Covid-19. Despite the end of the pandemic, however, the healthcare industry is still feeling its effects. Vaccine makers and pharmacy chains are seeing a steep decline in the number of people getting Covid...

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Beyond COVID vaccines: what else could mRNA technology do for our health?

Many people first became familiar with the term “mRNA” when Pfizer’s and Moderna’s COVID vaccines were rolled out. In the simplest terms, mRNA, which stands for messenger ribonucleic acid, is a type of genetic material that gives cells in our bodies instructions to make specific proteins.

The Independent UK

Pfizer cuts full-year outlook due to declining sales of Covid-19-related products

Shares of Pfizer are falling before the opening bell as the company cut its full-year outlook, citing declining sales of its COVID-19-related products

Fortune

Pfizer CEO Albert Bourla wants to tap 'Chinese science' as the drug company looks for a new target after COVID

Bourla hopes to bring the same speed in developing a COVID vaccine to discovering new cancer treatments.

Fortune

Modern companies need a purpose. Execs share advice

“It’s so incredibly powerful [to] have a very clear sense of your objectives.” Angela Hwang, Pfizer’s chief commercial officer said during a MPW panel.

Get all your
news in one place.

100's of premium titles.
One news app.

Sports Illustrated

Minneapolis Radio Station Trolls Taylor Swift, Travis Kelce With Billboard Before Chiefs-Vikings

Minnesota knew what audience to tailor to, no pun intended.

Sports Illustrated

Chiefs’ Travis Kelce Responds to Aaron Rodgers’s ‘Mr. Pfizer’ Jab

“Who knew I’d get into the vax wars with Aaron Rodgers, man?”

The Texas Tribune

Updated COVID-19 shot slowly rolls out in Texas, but access is spotty

Doses aren’t arriving at providers’ offices at uniform, predictable intervals. Shipments are largely dependent on individual providers’ ability to work out the logistics of ordering, stocking, training and paperwork.

Zenger

Travis Kelce’s Rumored Romance With Taylor Swift Boosts Brand Engagement

Pfizer and Campbell Soup see surge in searches and sales after dating rumors

StockNews.com

Which Pharma Stock Has More Potential Gains This Month: Pfizer (PFE) or Eli Lilly & Co. (LLY)?

The pharmaceutical industry is poised for sustained long-term growth due to increased investments in drug development and rapid technological advancements. While leading pharma stocks Pfizer (PFE) and Eli Lilly (LLY) stand to benefit, let us analyze which of these giants is poised for more gains this month. Keep reading.

Salon

Novavax COVID-19 vaccine approved

Vaccine uses different technology than Moderna and Pfizer's mRNA targeting strategy

Barchart

3 Quality Stocks to Defend Your Portfolio Against October Volatility

The sell-off in the U.S. stock market has deepened in October, and the Dow Jones Industrial Average is now negative for the year. Amid a challenging macro environment, Berkshire Hathaway, Pfizer, and Coca-Cola look like three good defensive stocks to buy.

1 … 21 22 23 24

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Wall Street Journal

The Kansas City Chiefs

1,087 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.